Market Research Logo

Global Multiple Sclerosis Drugs Market 2019-2023

Global Multiple Sclerosis Drugs Market 2019-2023

About this market

Globally, the prevalence of multiple sclerosis has increased due to genetic and environmental factors. Another reason which could be attributed to the increasing prevalence is the advances in diagnostic techniques in this therapy area. The prevalence of autoimmune diseases such as type 1 diabetes and certain infections such as infectious mononucleosis also increases the risk of multiple sclerosis. In 2008, the global prevalence of multiple sclerosis was estimated to be 0.031%, which increased to 0.032% in 2013. The prevalence of multiple sclerosis in Europe is also high. High disease prevalence drives the demand for drugs, thereby driving the growth of the market. Technavio’s analysts have predicted that the multiple sclerosis drugs market will register a CAGR of close to 6% by 2023.

Market Overview

Strong drug pipeline

With the increase in the prevalence of multiple sclerosis, there is a high unmet need for a strong pipeline of disease-modifying drugs. Current drugs for multiple sclerosis slow down the disease progression, but in many patients' responses to drugs are often variable and suboptimal. Ongoing R&D for the development of new drugs has resulted in the development of a strong drug pipeline for the treatment of multiple sclerosis. Therefore, the drug development initiatives by companies are expected to dive the market in the forecast period.

Side effects of multiple sclerosis drugs

The side effects associated with multiple sclerosis drugs can range from mild to serious. Therefore, side effects associated with these drugs can lead to low patient compliance and may hinder the growth of the global multiple sclerosis drugs market.

For the detailed list of factors that will drive and challenge the growth of the multiple sclerosis drugs market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s

competitive landscape and offering information on the products offered by companies.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Multiple Sclerosis Drugs Market 2019-2023

Technavio recognizes the following companies as the key players in the global multiple sclerosis drugs market: Bayer AG, Biogen, Merck KGaA, Novartis AG, Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the introduction of favorable reimbursement policies.”

According to the report, one of the major drivers for this market is the rising prevalence of multiple sclerosis has increased due to genetic and environmental factors.

Further, the report states that one of the major factors hindering the growth of this market is the challenges associated with diagnosis of multiple sclerosis.

Companies Mentioned

Bayer AG
Biogen
Merck KGaA
Novartis AG
Sanofi

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global central nervous system (CNS) disorders drugs market
      • Table Segments of global central nervous system (CNS) disorders drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline drugs in late-stage clinical trials
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by type
    • Table Type - Market share 2018-2023 (%)
    • Comparison by type
      • Table Comparison by type
    • Oral - Market size and forecast 2018-2023
      • Table Oral - Market size and forecast 2018-2023 ($ millions)
      • Table Oral - Year-over-year growth 2019-2023 (%)
    • Parenteral - Market size and forecast 2018-2023
      • Table Parenteral - Market size and forecast 2018-2023 ($ millions)
      • Table Parenteral - Year-over-year growth 2019-2023 (%)
    • Market opportunity by type
      • Table Market opportunity by type
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Bayer AG
      • Table Bayer AG - Vendor overview
      • Table Bayer AG - Business segments
      • Table Bayer AG - Organizational developments
      • Table Bayer AG - Geographic focus
      • Table Bayer AG - Segment focus
      • Table Bayer AG - Key offerings
    • Biogen
      • Table Biogen - Vendor overview
      • Table Biogen - Business segments
      • Table Biogen - Organizational developments
      • Table Biogen - Geographic focus
      • Table Biogen - Key offerings
    • Merck KGaA
      • Table Merck KGaA - Vendor overview
      • Table Merck KGaA - Business segments
      • Table Merck KGaA - Organizational developments
      • Table Merck KGaA - Geographic focus
      • Table Merck KGaA - Segment focus
      • Table Merck KGaA - Key offerings
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
    • Sanofi
      • Table Sanofi - Vendor overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi - Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report